Vanguard Group Inc Design Therapeutics, Inc. Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

A detailed history of Vanguard Group Inc transactions in Design Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,394,024 shares of DSGN stock, worth $9.63 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,394,024

Previous 1,296,788 7.5%

Holding current value

$9.63 Million

Previous $4.34 Million 72.63%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$3.19 - $5.88 $310,182 - $571,747	97,236 Added 7.5%	1,394,024 $7.5 Million
Q2 2024 Aug 13, 2024	BUY	$3.23 - $4.77 $34,967 - $51,640	10,826 Added 0.84%	1,296,788 $4.34 Million
Q1 2024 May 10, 2024	BUY	$2.27 - $4.03 $655,582 - $1.16 Million	288,803 Added 28.96%	1,285,962 $5.18 Million
Q4 2023 Feb 14, 2024	BUY	$1.99 - $2.76 $20,791 - $28,836	10,448 Added 1.06%	997,159 $2.64 Million
Q3 2023 Nov 14, 2023	BUY	$2.05 - $8.14 $7,045 - $27,977	3,437 Added 0.35%	986,711 $2.33 Million
Q2 2023 Aug 14, 2023	SELL	$4.99 - $7.64 $1.5 Million - $2.29 Million	-299,769 Reduced 23.36%	983,274 $6.19 Million
Q1 2023 May 15, 2023	SELL	$5.5 - $9.77 $1.53 Million - $2.72 Million	-278,657 Reduced 17.84%	1,283,043 $7.4 Million
Q4 2022 Feb 10, 2023	BUY	$7.86 - $17.2 $78,207 - $171,140	9,950 Added 0.64%	1,561,700 $16 Million
Q3 2022 Nov 14, 2022	BUY	$14.09 - $25.57 $3.83 Million - $6.95 Million	271,706 Added 21.23%	1,551,750 $25.9 Million
Q2 2022 Aug 12, 2022	SELL	$9.91 - $17.33 $5.89 Million - $10.3 Million	-593,849 Reduced 31.69%	1,280,044 $17.9 Million
Q1 2022 May 13, 2022	BUY	$11.17 - $20.89 $37,877 - $70,837	3,391 Added 0.18%	1,873,893 $30.3 Million
Q4 2021 Feb 14, 2022	BUY	$13.64 - $21.41 $10.7 Million - $16.7 Million	782,301 Added 71.89%	1,870,502 $40 Million
Q3 2021 Nov 12, 2021	SELL	$13.99 - $20.03 $1.65 Million - $2.36 Million	-117,765 Reduced 9.77%	1,088,201 $16 Million
Q2 2021 Aug 13, 2021	BUY	$19.02 - $29.78 $22.9 Million - $35.9 Million	1,205,966 New	1,205,966 $24 Million

Others Institutions Holding DSGN

# of Institutions

106

Shares Held

31.7M

Call Options Held

1.1K

Put Options Held

21.3K

View Full List

About Design Therapeutics, Inc.

Ticker DSGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,807,900
Market Cap $386M
Description
Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ syste...

More about DSGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Design Therapeutics, Inc. Transaction History